Celljevity Demonstrates Cartilage Regeneration in Osteoarthritis Clinical Trial
Breakthrough study shows measurable cartilage regrowth using patient’s own reprogrammed cells, offering alternative to joint replacement surgery A revolutionary development in orthopedic medicine has emerged from clinical research by Celljevity, where the Dutch biotechnology company has demonstrated actual cartilage regeneration in osteoarthritis patients using cellular reprogramming therapy. The randomized controlled trial, involving 80 patients, showed…
Read More